Bristol-Myers Squibb Co. (BMY) Tops Q3 EPS by 3c; Narrows FY11 Guidance
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.65 +1.49%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q3 EPS of $0.61, $0.03 better than the analyst estimate of $0.58. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.3 billion.
Bristol-Myers Squibb Co. sees FY2011 EPS of $2.25-$2.30, versus prior guidance of $2.20-$2.30 and the consensus of $2.8.
Bristol-Myers Squibb Co. sees FY2011 EPS of $2.25-$2.30, versus prior guidance of $2.20-$2.30 and the consensus of $2.8.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
